| Hazard Information | Back Directory | [Uses]
JT002 is an orally active inhibitor of the NLRP3 inflammasome. JT002 reduces NLRP3-dependent proinflammatory cytokine (such as IL-1β, IL-1α, IL-18) production and pyroptosis. JT002 blocks NLRP3 inflammasome complex formation. JT002 reduces airway hyperresponsiveness and airway neutrophilia in mice[1]. | [References]
[1] Ambrus-Aikelin G, et al. JT002, a small molecule inhibitor of the NLRP3 inflammasome for the treatment of autoinflammatory disorders. Sci Rep. 2023 Aug 19;13(1):13524. DOI:10.1038/s41598-023-39805-z |
|
| Company Name: |
ChemOrigin Pharm
|
| Telephone: |
15026428026 19002516454 |
| Website: |
www.chemorigin.com |
|